| the viral RNA polymerase replicates the viral RNA and this can be exploited for direct RNA to RNA amplification. to wit : https://chempedia.info/info/viral_rna_polymerase/ I was making reference to the process of cyclic amplification, in a manner palatable to non biology literate individuals The same _basic_ principles as can be read in the chempedia example the process of RNApol replication of RNA from RNA template is error prone, thus it is superior to create a large copy number of DNA template corresponding to the mRNA desired as DNA amplification is self correcting for the most part. dependent upon experimental or procedural requirements it may be desirable to produce error prone replication variants of the RNA template, however it is quite possible to go from RNA template to RNA product with RNApol. due to the fragile nature of RNA there must be some shielding or , a low cycle rate is used in conjunction with immediate harvest and stabilization of the product. the sars-2 covid19 virus replicates by way of an RNA dependent RNApol [rdRNApol] https://pubmed.ncbi.nlm.nih.gov/32277040/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164392/ |
Producing RNA from DNA amplicons (PCR products) makes sense, I'm curious if that is the source of material from in the vaccines, or if it's artificially synthesized?
Would that be a trade secret?